期刊文献+

炎症性肠病湿热转化的免疫学基础研究 被引量:2

The immunological basis of inflammatory bowel disease's damp-heat conversion
下载PDF
导出
摘要 目的探讨炎症性肠病(inflammatory bowel disease,IBD)湿热转化不同证型的免疫学基础。方法采用综合因素(饮食加气候环境加药物加致病生物因子)造模复制IBD湿热证动物模型。于造模完成后分别检测TNF-α、白细胞介素(IL-1β、IL-4、IL-6、IL-10)和淋巴T细胞抗体(CD3+、CD4+、CD8+)。结果造模在发病条件、主要症状和体征方面近似IBD湿热证型。实验组血清TNF-α、IL-1β、IL-6均低于对照组(P<0.05),IBD模型组与对照组的血清IL-4、IL-10和CD4+抗原比较均无统计学意义(P>0.05)。结论 TNF-α、IL-1β、IL-6参与了IBD湿热证的发病过程,IBD的免疫过程是一个非特异性免疫过程。 Objective To study,the immunological basis of damp-heat conversion of different syndromes of inflammatory bowel disease (IBD). Methods Animal models of inflammatory bowel disease damp-heat syndrome were developed by using various factors including diet, climate, drugs, and pathogenic biological factors. TNF-o~, interleukins ( IL-113, IL-4, IL-6, and IL-10) and lymphoid T cell antibodies (CD3+ , CIM+ , CD8+) were measured after the models were completed. Results The body temperature of animals with IBD damp-heat syndromes was different from that of normal animals. Serum levels of TNF-c~, IL-113 and IL-6 of the experimental group were significantly lower than that of the Control group (P 〈 0. 05 ). However, no significant difference in serum levels of IL-4 and IL-10, and numbers of CIM~ T cells were found between the IBD groups and the control group. Conclusion TNF-ct,IL-113,IL-6 may be in- volved in pathogenesis of IBD with damp-heat syndromes. The immune response of IBD with damp-heat syndrome is a non-specific im- mune process.
出处 《实用医院临床杂志》 2013年第3期50-53,共4页 Practical Journal of Clinical Medicine
关键词 炎症性肠病 湿热转化 动物模型 免疫细胞因子 Inflammatory bowel disease Damp-heat conversion Animal models Immune cytokines
  • 相关文献

参考文献6

二级参考文献18

  • 1麦国丰,简燕婷,杨玉捷,崔海宏,张亚历.姜黄素对肠炎大鼠肠黏膜基质金属蛋白酶-9的调控[J].第四军医大学学报,2005,26(14):1257-1260. 被引量:14
  • 2杨运高.温病湿热证动物模型研制的方法学比较[J].中国中医基础医学杂志,1998,:172-172.
  • 3Wendelsdorf K,Bassaganya-Riera J,Hontecillas R,et al.Model of colonic inflammation:immune modulatory mechanisms in inflammatory bowel disease[J].J Theor Biol,2010,264(4):1225.
  • 4Dharmani P,Chadee K.Biologic therapies against inflammatory bowel disease:a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key[J].Curr Mol Pharmacol,2008,1(3):195.
  • 5Mudter J,Neurath MF.Il-6 signaling in inflammatory bowel disease:pathophysiological role and clinical relevance[J].Inflamm Bowel Dis,2007,13(8):1016.
  • 6Wilson MS,Ramalingam TR,Rivollier A,et al.Colitis and intestinal inflammation in IL10-/-mice results from IL-13Rα2-mediated attenuation of IL-13 activity[J].Gastroenterology,2011,140(1):254.
  • 7Li CS,Zhang Q,Lee KJ,et al.Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean Population[J].Gastroenferol Hepatol,2009,24:1692.
  • 8Myyung SJ,Yang SK,Jung,HY,et al.DRB11502 confers susceptibility to ulcerative colitis,but is negatively associated with its intractability:a Korean study[J].Int J Colorectal Dis,2002,17(4):233.
  • 9Weigert J,Obermeier F,Neumeier M,et al.Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease[J].Inflamm Bowel Dis,2010,16(4):630.
  • 10Sung JJ,Kamm MA,Marteau P.Asian perspectives in management of inflammatory bowel disease:findings from a recent survey[J].J Gastroenterol Hepatol,2010,25(1):183.

共引文献49

同被引文献30

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部